|
|
Volumn 287, Issue 13, 2002, Pages 1635-1637
|
|
Researchers explore new anti-HIV agents
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 [5 (4 FLUOROBENZYL) 2 FURYL] 3 (1,2,4 TRIAZOL 3 YL) 1,3 PROPANEDIONE;
4 BENZOYL 1 [(4 METHOXY 1H PYRROLO[2,3 B]PYRIDIN 3 YL)OXOACETYL] 2 METHYLPIPERAZINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CHEMOKINE RECEPTOR CCR5;
CHEMOKINE RECEPTOR CXCR4;
EFAVIRENZ;
ENFUVIRTIDE;
ETRAVIRINE;
GLYCOPROTEIN GP 120;
INTEGRASE;
INTEGRASE INHIBITOR;
NEVIRAPINE;
PROTEINASE;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SCH C;
UNCLASSIFIED DRUG;
VICRIVIROC;
VIRUS ENZYME;
CHEMICAL STRUCTURE;
CLINICAL TRIAL;
DRUG CLASSIFICATION;
DRUG INDICATION;
DRUG MECHANISM;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG TOLERABILITY;
ENZYME ACTIVE SITE;
ENZYME BINDING;
ENZYME INHIBITION;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VITRO STUDY;
LONG QT SYNDROME;
PRIORITY JOURNAL;
PROTEINASE INHIBITION;
RECEPTOR BINDING;
RESEARCH;
SHORT SURVEY;
TREATMENT FAILURE;
VIRUS LOAD;
VIRUS REPLICATION;
VIRUS STRAIN;
|
|
EID: 0037012460
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.13.1635 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|